BLCO
Bausch + Lomb Corp.
NYSE · Healthcare · Medical - Instruments & Supplies · CA
$20.68
+3.25%Year over year
Reported trailing growth
- Revenue
- +8.8%
- EBITDA
- +32.7%
- EBIT
- +288.9%
- EPS
- +64.3%
- Free cash flow
- +230.5%
- Operating cash flow
- +222.9%
Forward estimates
Based on analyst estimates
- Revenue
- +6.2%
- EBITDA
- +97.2%
- EPS
- +476.7%
Three-year CAGR
- Revenue
- +10.6%
- EBITDA
- -3.6%
- EBIT
- -3.2%
- Net income
- -13.6%
- EPS
- -13.3%
- Free cash flow
- -11.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026